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Available online 19 December 2014AbstractIntroduction: Mucoepidermoid carcinoma (MEC) is one of the most common malignant salivary gland neoplasms. It represents
diverse biological aggressiveness and prognosis. Estrogen receptors (ER) are activated by sex hormone Estrogen. HER2 is a
member of epidermal growth factor receptors. Both ER and HER2 have been implicated in the pathogenesis and prognosis of many
neoplasms particularly breast. Little is known about their role in MEC.
Materials & methods: Normal salivary gland, low and high gradeMEC tissue specimens were stained with anti-ER and anti-HER2
antibodies and the expression was quantified using ImagJ.
Results: Normal salivary gland tissues were negative for both ER and HER2 while MEC was positive for both of them. Inter-
estingly, ER and HER2 expression was higher in high grade MEC than in low grade MEC.
Conclusion: ER and HER2 expression in MEC is correlated with its grade and may play a role in development and progression of
MEC.
© 2014, Hosting by Elsevier B.V. on behalf of the Faculty of Dentistry, Tanta University.
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Benign and malignant salivary gland neoplasms
constitute a significant part of oral tumors after squa-
mous cell carcinoma [1]. Mucoepidermoid carcinoma
(MEC) is considered one of the most common salivary* Corresponding author. Tel.: þ447510846675.
E-mail address: radienelattar@yahoo.com (R.H. El-Attar).
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Open access under CC BY-NC-ND license.gland malignancies and it is also the most common
salivary gland malignancy in children [2].
MEC is believed to arise from the reserve cells of
excretory ducts and the tumor consists of three cell
types; mucous cells, epidermoid cells and intermediate
cells [3]. As the results of considerable variations in
type, distribution and growth pattern of MEC cells,
several histological variants are seen; low, intermediate
and high-grades [4].
MEC manifests diverse biological aggressiveness
showing association with its histological grade andentistry, Tanta University.
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studies [1,5&,6].
Estrogen receptors (ER) are a group of proteins that
are activated by the hormone estrogen and that have
two different forms; alpha and beta [7]. Sun et al.
demonstrated that ER might play different roles in the
development of breast cancer [8].
Human epidermal growth factor receptor 2 (HER2)
is a member of epidermal growth factor receptor
family. It acts as oncogene, its overexpression has been
shown to play an essential role in the development and
progression of aggressive types of breast cancer [9].
Therefore, both ER and HER2 are the most frequently
used molecular markers in breast cancer with different
outcomes [10].
Mammary and salivary glands are tubuloacinar
exocrine glands and share similar morphological
characteristics. Comparing the tumors arising from
these two different sites, similar histological features
are observed. Although the cancers differ in incidence
and clinical behavior, certain biological features iden-
tified in both entities have been described, and poten-
tial common therapeutic approaches have been
considered [11].
In a previous study, expression of ER suggested that
estrogen may have a biological role in oral mucosa and
salivary glands [12]. The advent of sex hormone an-
tagonists and their use in treatment of patients with ER
positive breast carcinomas has prompted investigators
to evaluate the expression of ER in a variety of tumors
including those arising in salivary glands [13].
Moreover, HER2 expression was demonstrated in
salivary gland carcinomas and that expression was
dependent on type of carcinoma studied [14].
To the best of our knowledge, there are few reports
regarding the expression of both ER and HER2 in
MEC in particular. Therefore, the present study was
undertaken to evaluate the expression of ER and HER2
in low and high-grade MEC in order to elucidate a
possible role of either or both in development and
progression of salivary MEC.
2. Materials and methods
2.1. Case selection
5 cases of normal salivary gland, 10 cases low and
10 cases high grade MECs were obtained from the
archives of Oral Pathology Department, Faculty of
Dentistry, Tanta University in the period from 2013 to
2014. H&E stained slides of low and high grade MEC
were reviewed and confirmed for diagnosis. Normalsalivary gland tissues were obtained from cases
of mucocele.
2.2. Immunohistochemistry
Formalin fixed paraffin embedded (FFPE) blocks of
normal salivary gland, low and high-grade MEC were
cut into 4 um thick sections, de-paraffinized in xylene
and rehydrated in descending grades of ethanol.
Blocking of endogenous peroxidase activity was per-
formed using methanol containing 0.3% of hydrogen
peroxide for 30 min. Antigen retrieval was done using
EDTA (PH8). Then, the sections were incubated with
primary antibodies for one hour in a humid chamber
(anti-ER antibody (cat# SP1 lab vision) at 1:100 con-
centrations and anti-HER2 antibody (cat# AB-17 lab
vision) at 1:400 concentration). The slides were rinsed
in phosphate buffered saline (PBS) and secondary
antibody was applied at 1:1000 concentrations and
incubated for 30 min. The sections were rinsed in PBS
and covered by Diaminobenzidine (DAKO, Glostrup,
Denmark) for detection of the reaction. The sections
were then counterstained with Meyer's hematoxylin
and dehydrated in ascending grades of ethanol. Finally,
the slides were mounted and examined under light
microscope. Taking in consideration the percentage of
positive cells and the overall staining intensity, ER and
HER2 were considered positive if over than 10% of
cells showed strong or diffuse staining. ER and HER2
were considered negative if less than 10% of the cells
showed weak or no staining [15].
2.3. Quantification of positive staining
Protein expression for both antigens was quantified
in the study cases using ImageJ program. The quanti-
fication was performed in 3 different fields in each case
and the average was calculated and used to represent
level of expression. Expression level for both ER and
HER2 in normal salivary gland, low and high grade
MEC were blotted in graphs using Microsoft Excel
2010 program.
3. Results
3.1. ER expression
Estrogen antibody showed positive cytoplasmic
expression in both low and high grade MEC. The
expression intensity was higher in high grade than low
grade. Normal salivary gland tissue was negative for
estrogen except for positive staining at intercalated
Fig. 1. Normal, low and high grade mucoepidermoid carcinoma FFPE tissue sections were immunostained with anti-ER antibody and level of
expression was quantified in three different fields of each case using ImagJ program and average was used to blot graph bars. A) Normal salivary
gland tissue. B) Low grade mucoepidermoid carcinoma. C) High grade mucoepidermoid carcinoma (20). D) Graph showing level of ER
expression in three cases (Error bars represent standard deviation).
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weak positivity for estrogen, stromal cells were nega-
tive (Fig. 1 B). High grade MEC cells shown strong
positivity for estrogen and similarly the stromal cells
were negative (Fig. 1 C). The expression level was
measured using ImageJ and blotted in graph showed in
(Fig. 1 D). The estrogen expression level in high grade
MEC was almost two folds higher than that in low
grade MEC.3.2. HER2 expression
HER2 showed positive cytoplasmic expression.
Both low and high grade MEC were positive for
HER2 but with different intensities. Normal salivary
gland was negative for HER2 (Fig. 2 A). HER2
expression was strong in high grade MEC (Fig. 2 C)
while it was weak to moderate in low grade (Fig. 2 B).
Level of expression was quantified using ImagJ as
Fig. 2. Normal, low and high grade mucoepidermoid carcinoma FFPE tissue sections were immunostained with anti-HER2 antibody and level of
expression was quantified in three different fields of each case using ImagJ program and average was used to blot graph bars. A) Normal salivary
gland tissue. B) Low grade mucoepidermoid carcinoma. C) High grade mucoepidermoid carcinoma (20). D) Graph showing level of ER
expression in three cases (Error bars represent standard deviation).
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graph; HER2 expression in high grade MEC was two
folds or more than in low grade MEC as shown in
(Fig. 2 D).
4. Discussion
Malignant salivary gland tumors are rare lesions,
often with poor prognosis. MEC is one of the most
common malignant salivary gland tumors with diversebiological behavior [4]. Little is known about the po-
tential role of sex hormones and epidermal growth
factor receptor family in pathogenesis and progression
of malignant salivary gland tumors. This study is the
first to illustrate the expression of both ER and HER2
in low and high-grade MEC.
In this study, both ER and HER2 showed positive
expression in MEC. Interestingly, their expression was
higher in high-grade MEC than low-grade variant. Our
results are in agreement with those reported in a
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few cases of malignant salivary gland tumors [13]. All
benign tumors were negative for ER in the same study.
Moreover, HER2 expression was demonstrated in
malignant tumors of salivary glands particularly in
salivary duct carcinoma [14].
It was postulated that a positive role for sex hor-
mones in the histogenesis of salivary gland tumors
could exist based on the common occurrence of sali-
vary gland tumors in females than in males that in turn
varies with tumor type [16]. In addition, Matsuo et al.
reported the important role of estrogen pathway in
promoting lymphatic or vascular spread of high-grade
serous ovarian carcinoma [17].
On the other hand, HER2 has the ability for heter-
odimerization with any other three HER proteins and
therefore, it can participate in a signal transduction
cascade with different effects that enhance the malig-
nant phenotype [18].
In our results, normal salivary gland tissues were
negative for both ER and HER2.
These findings coincide with those of another report
that revealed no expression of ER in salivary glands by
immunohistochemistry, but the expressionwas evidenced
by western blot and RT-PCR (12). These results probably
attributed to either low level of expressed protein, short
half life of the protein or difficulties in identifying epi-
topes by immunohistochemistry technique.
In the light of fore mentioned observations, results
in the current study are the first to explore the
expression of both ER and HER2 in low and high-
grade MEC and the expression of both was more in
high-grade MEC. Therefore, a possible role for both in
development and progression of MEC may exist and
they could be useful prognostic markers in MEC.
Both ER and HER2 may represent a potential
therapeutic approach for MEC. However, further in-
vestigations using large number of MEC cases and
different malignant salivary gland tumors are recom-
mended to clearly identify the exact role of both ER
and HER2 in salivary gland carcinogenesis.
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